Trident Texofab (BOM:540726) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


BOM:540726 Trident Texofab Ltd BOM:540726
64 GF Score
Price ₹31.95
GF Value ₹63.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Trident Texofab Research & Development?

Trident Texofab BOM:540726 -2.17% 64 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:540726 with a GF Score™ of 64/100 and a GF Value™ of ₹63.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Trident Texofab's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Trident Texofab  (BOM:540726) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Trident Texofab Research & Development Related Terms

Trident Texofab Research & Development Historical Data

* Premium members only.

The historical data trend for Trident Texofab's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trident Texofab Research & Development Chart

Trident Texofab Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.04 0.03 0.00 0.00

Trident Texofab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:540726
64GF Score
Trident Texofab Ltd BOM:540726
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trident Texofab Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Trident Texofab (BOM:540726) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Trident Texofab and its competitors.
Is Trident Texofab's Research & Development too high?
Trident Texofab's current Research & Development is ₹0 Mil. Overall, Trident Texofab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's Research & Development compare to competitors?
Trident Texofab's Research & Development of ₹0 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Manufacturing - Apparel & Accessories company?
A good Research & Development depends on the Manufacturing - Apparel & Accessories industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Trident Texofab and its competitors. Trident Texofab's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.39, compared to a current price of ₹31.95 — trading 49.6% below its estimated fair value. The current Research & Development is ₹0 Mil. Trident Texofab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trident Texofab (BOM:540726) Overvalued in 2026?

Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued. The current stock price of ₹31.95 is trading 49.6% below its estimated GF Value™ of ₹63.39. GuruFocus considers Trident Texofab to be Possible Value Trap.

Key valuation signals for BOM:540726:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹63.39 vs. price of ₹31.95 (49.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trident Texofab Business Description

Address Ring Road, Nodh-4/1650, Sahara Darwaja, 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Surat, GJ, IND, 395003
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
64GF Score

Get the complete analysis for BOM:540726

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹31.95
Price
₹63.39
GF Value